Most health experts agree that early and aggressive treatment for COVID-19 helps to reduce the potential for long COVID symptoms and reduces the risk of severe disease. From the beginning, the pharmaceutical industry has sought to develop new and expensive antiviral drugs to treat the coronavirus responsible for COVID-19 with an aim at profits. The… Read More »
Summer savings are heating up. Purchase your in-person ticket for 3BL Forum today to join us on October 25th in New York City. The past two years have brought unprecedented challenges, and we’re all asking ourselves: Now What? Let’s answer that question together. 3BL Forum is returning this fall, and you won’t want to miss… Read More »
In this interview, Paul Connett, Ph.D., cofounder of and scientific adviser for the Fluoride Action Network (FAN), provides an annual status update for 2022. As long-time readers of this newsletter will know, we’ve supported and promoted FAN for over a decade. Fluoride is one of the many unnecessary barriers to optimal health, and we’ve been… Read More »
In a rather shocking turn of events, the U.S. Food and Drug Administration sneaked in a “Future Framework”1 scheme that will allow Pfizer and Moderna to reformulate and release updated COVID shots without conducting any additional human clinical trials, other than what’s already been done.2,3,4 FDA Rewrites the Rules on the Fly A vote on… Read More »